"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Supriya Lifescience Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Satish Waman Wagh
Home : Indian Private	Book Value: 134.4133852
BSE Code : 543434	Market Cap: 5330.78
NSE Code : SUPRIYA	P / E : 28.72

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Type	3Qtr	2Qtr	1Qtr	4Qtr
Net Sales	206.44	199.83	145.07	184.11
Other Income	2.61	2.73	2.67	2.98
Total Income	209.05	202.56	147.75	187.08
Total Expenditure	134.82	127.19	93.37	116.53
Operating Profit	74.24	75.37	54.38	70.56
Interest	0.49	0.42	0.51	0.42
Gross Profit	73.74	74.96	53.86	70.14
Depreciation	6.82	6.64	6.45	6.08
Tax	15.32	15.16	10.54	12.77
Deferred Tax	1.92	2.73	2.09	0.91
Reported Profit After Tax	49.68	50.43	34.79	50.38

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView